Yes, we are lucky and I'm grateful for cardio-protection but don't need to thank CoH for that ... the RAC team found it themselves through diligent investigation!
On that note, I love how in this week's presentation and interview Phil Lynch says something along the lines of "our very conservative estimates of value" for FTO and cardio-protection while, off the top of my head, they're suggesting that the total addressable market for each of them could be $100B per year, and they're estimating the current subset from known programs could be worth over $60 per share for FTO alone using RAC market share estimates and industry revenue multiples amply referenced by Wombat777!
Don't have a good year in 2022, have a great year!
Ann: Race-Chaim Sheba FTO Biomarker Collaboration, page-107
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.050(3.03%) |
Mkt cap ! $289.6M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.70 | $1.63 | $181.9K | 109.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11946 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 27579 | 4 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |